Indefinite Delivery Contract 75N93022D00019
Award Date
1/14/22
Last Date to Order
1/13/32
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Duke University
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Pricing Type
Cost Plus Fixed Fee
Legislative Mandate
Employment Eligibility Verification
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
This Indefinite Delivery Contract (IDC) was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Duke University's Office of Research Administration Division as the prime contractor. The $20,000,000 IDC falls under the NIAID Animal Models of Infectious Diseases 2010-2017 multiple-award IDIQ contract vehicle and does not have any set-aside designations. Under this IDC, Duke University will...
The National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, awarded this $107,274,471 Indefinite Delivery/Indefinite Quantity (IDIQ) contract to the University of North Carolina at Chapel Hill (UNC-CH) to provide preclinical development support for candidate products and drug development activities related to infectious diseases like HIV, hepatitis, and tuberculosis. The contract encompasses a wide range of services including in...
The National Institute of Allergy and Infectious Diseases awarded an indefinite delivery contract to FHI Clinical Inc. to provide comprehensive and rapid response research programs. The contract has a potential value of $545,452,906 over a seven-year ordering period through August 2028. Two task orders have been issued against it to date, one for $332,178 and another for $2,000. Under the contract, FHI Clinical Inc. will support the NIAID's mission to conduct biomedical research on infectious,...
The National Institutes of Health National Institute of Allergy and Infectious Diseases awarded an Indefinite Delivery Contract to PPD Development LP with a potential value of $545,452,906 to provide comprehensive and rapid response capabilities for research programs through September 2028. Task orders issued against the contract include over $132 million for clinical trial management support services relating to COVID-19, as well as orders valued at $2.33 million, $2 million, and $82.5...
The National Institute of Allergy and Infectious Diseases, a component of the National Institutes of Health within the Department of Health and Human Services, awarded multiple Indefinite Delivery/Indefinite Quantity contracts valued collectively up to $364.5 million to support preclinical and translational vaccine development services for HIV vaccines and other candidate agents. The ordering period is from December 2021 through November 2028. Under the contracts, the prime contractors will...
The federal contract IDV award, with ID 75N93024D00003, is a single-award Indefinite Delivery Contract (IDC) issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency. The prime contractor is Duke University's Office of Research Administration Division. The contract, valued at a ceiling of $48,645,049.00, is for the provision of an External Quality Assurance Program Oversight Laboratory (EQAPOL) service. The original solicitation, number 75N93022R00034, was a...
This is a multiple award Indefinite Delivery Contract (IDC) awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to provide comprehensive early phase clinical trial services. The $346.6 million contract, titled "Early Phase Clinical Trial Units (EPCTU)", facilitates Phase 0 through Phase II trials of investigational products against infectious diseases over a 10-year ordering period from...
The National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services (HHS), awarded an Indefinite Delivery/Indefinite Quantity (IDIQ) contract titled "Early Phase Clinical Trial Units (EPCTU)" to Icon Government And Public Health Solutions, Inc., a foreign-owned, for-profit organization. The $346.6 million IDIQ will support Phase 0 through Phase II clinical trials of investigational products against infectious diseases over a 10-year...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services, has awarded a single-award Indefinite Delivery Contract (IDC) valued at $146.3 million to the University of Cincinnati. The contract, titled "Pre-Clinical Models of Infectious Diseases - Task Area A," has an ordering period through July 2031. The purpose of this IDC is to provide NIAID with the capability and capacity to develop, refine, and employ...
The National Institute of Allergy and Infectious Diseases awarded an indefinite delivery contract to The Emmes Company LLC on September 1, 2021. With a potential value of $545,452,906 over seven years, this single award IDC supports NIAID's research programs through a broad range of services. Task Order 1 issued under the contract is a firm fixed price order valued at $2,000 to satisfy minimum requirements. Performance will take place in Potomac, MD from September 1, 2021 through August 31,...